Conversion response and prognostic factors in HCC patients with macrovascular invasion treated with atezolizumab plus bevacizumab K. Wang,H. Sun, X. Bai,Z-Y. Huang, T. Song,M. Chen, M. Kuang, B. Xiang, Y. Zeng,L-X. Liu,D. Li,Y. Chen, J. Cai, B. Xing, T. Peng, X. Zhang, X. Zhu, J. Zhou, J. Fan, F. ShenAnnals of Oncology（2023）引用 0|浏览1暂无评分AI 理解论文溯源树样例生成溯源树，研究论文发展脉络Chat Paper正在生成论文摘要
